ResearcherNingbo UniversityActive in the last 2 years

Libin Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4035-0828; OpenAlex author ID A5101641385. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper

Papers 2

Hollow Mesoporous Carbon Nanospheres Derived from Metal-Organic Frameworks for Efficient Sono-immunotherapy against Pancreatic Cancer. Co-author DOI 10.34133/cbsystems.0247 ↗
TiSe2-mediated sonodynamic and checkpoint blockade combined immunotherapy in hypoxic pancreatic cancer. Co-author DOI 10.1186/s12951-022-01659-4 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Shengmin Zhang · 1 shared paper, 2025 · strength 0.33
- Paper Hollow Mesoporous Carbon Nanospheres Derived from Metal-Organic Frameworks for Efficient Sono-immunotherapy against Pan… DOI 10.34133/cbsystems.0247 ↗
Youfeng Xu · 1 shared paper, 2022 · strength 0.15
- Paper TiSe2-mediated sonodynamic and checkpoint blockade combined immunotherapy in hypoxic pancreatic cancer. DOI 10.1186/s12951-022-01659-4 ↗
Jing Cao · 1 shared paper, 2022 · strength 0.15
- Paper TiSe2-mediated sonodynamic and checkpoint blockade combined immunotherapy in hypoxic pancreatic cancer. DOI 10.1186/s12951-022-01659-4 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.